The orexins/hypocretins and schizophrenia.

@article{Deutch2006TheOA,
  title={The orexins/hypocretins and schizophrenia.},
  author={Ariel Y. Deutch and Michael Bubser},
  journal={Schizophrenia bulletin},
  year={2006},
  volume={33 6},
  pages={
          1277-83
        }
}
Advances in molecular biology have led to new peptides and proteins being discovered on a regular basis, including the isolation of a number of neurotransmitter candidates. Rarely, however, do these immediately capture the attention of the scientific community. The isolation and characterization of the orexin/hypocretin peptides a decade ago resulted in a slew of studies that have helped clarified their diverse functions, including prominent roles in arousal and appetitive behavior. A number of… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 14 CITATIONS

Orexins/hypocretins and aminergic systems.

VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Insomnia in patients with schizophrenia: current understanding and treatment options

  • Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • 2019
VIEW 2 EXCERPTS
CITES BACKGROUND

Role of lateral hypothalamus in two aspects of attention in associative learning.

  • The European journal of neuroscience
  • 2014
VIEW 1 EXCERPT
CITES BACKGROUND

Cognitive activation by central thalamic stimulation: the yerkes-dodson law revisited.

  • Dose-response : a publication of International Hormesis Society
  • 2011
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 81 REFERENCES